CHARLOTTESVILLE, Virginia, July 13, 2010 /PRNewswire/ — Biovista announced today the appointment of Mr. Clifford H. Farrah, President and Chairman of The Beacon Group, to its Advisory Board. “We are very excited to have Cliff join our Advisory Board,” said Aris Persidis, President of Biovista. “Cliff brings a wealth of direct commercial development experience in … Read More
Author: Vassilis Virvilis
Biovista Featured in CHI’s InsightPharma Report on Drug Repositioning
Biovista Inc., Charlottesville, July 7, 2010: Biovista today announced that it is a featured company in InsightPharma’s report on Drug Repositioning. The report “Drug Repositioning: Extracting Added Value from Prior R&D Investments” by Dr. Hermann A.M. Mucke explains the basic issues surrounding drug repositioning as a pipeline development and/or lice cycle management strategy, covers the … Read More
Biovista to present at the 8th Int’l Conference on Pathways, Networks, and Systems Medicine
Biovista Inc., Charlottesville, July 7, 2010: Biovista today announced that it will be presenting at the 8th International Conference on Pathways, Networks, and Systems Medicine to be held at the Sheraton rhodes hotel in Rhodes, July 9 – 14, 2010. Dr Andreas Persidis, CEO of Biovista Inc. will present on Sunday 11 July, 11:45am local … Read More
Biovista at OneMedForum New York 2010
Graham Anthony, CFO of Biovista, Inc., presents at the OneMedForum New York 2010.
BioWorld: Obesity Report : Tipping the Market Scales with Biotech & Med-Tech Regimens
BioWorld & Medical Device Daily BioVista Inc. has drugs in various stages of research and preclinical development for eye disorders, diabetes and obesity. According to its website, the Charlottesville, Va.-based company has identified four novel targets involved in diabetes and obesity that lend them- selves to the development of RNAi drugs. Using artificial intelligence (AI), … Read More